New drug aims to cut opioid use after knee replacement
NCT ID NCT07624526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding suzetrigine (Journavx) to standard pain management can lower pain and reduce the need for opioid painkillers after total knee replacement. About 75 adults with knee arthritis will take the drug as part of their post-surgery care. The goal is to improve pain control and limit opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Clinic
Atlanta, Georgia, 30322, United States
-
Emory Clinic at Executive Park
Atlanta, Georgia, 30329, United States
-
Emory Orthopaedics and Spine Center
Atlanta, Georgia, 30329, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Carb diet ease knee pain? a study investigates racial differences
- Blocking knee blood vessels may offer new pain relief for severe osteoarthritis
- Which knee implant lasts longer? a Head-to-Head test
- Can cutting carbs curb knee pain? a diet trial puts it to the test
- Can virtual reality make knee pain therapy more engaging?
- Can a diabetes drug improve joint replacement outcomes?